A. Achari
Epidemiology · 2017
A researcher in the Science corpus: 1 paper; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 26 citations into it
- Physiology — 21 citations into it
- Molecular Biology — 17 citations into it
- Endocrine and Autonomic Systems — 10 citations into it
Whom A. Achari trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- J. Díez
- Toshimasa Yamauchi
- P. Iglesias
- G. Fantuzzi
- S. Summers
- K. Inoki
- A. Berg
- N. Ouchi
- U. Pajvani
- Bruce E. Kemp
Papers from A. Achari's perspective
Ordered by how strongly the researchers A. Achari trusts endorse each paper. Same corpus, a different order for every researcher.
- Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. (Proceedings of the National Academy of Sciences of the United States of America)
- The adipocyte-secreted protein Acrp30 enhances hepatic insulin action (Nature Medicine)
- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity (Nature Medicine)
- Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase (Nature Medicine)
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effects (Nature)
- Role of Adiponectin in Preventing Vascular Stenosis (Journal of Biological Chemistry)
- Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin (Circulation Research)
- Obesity-associated improvements in metabolic profile through expansion of adipose tissue. (Journal of Clinical Investigation)
- Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway (Circulation)
- Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin (Journal of Biological Chemistry)
Their papers
- Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction (2017) — 1,036 citations